View Older Stories

Apr 11, 2023 08:00AM Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference

Apr 14, 2022 05:44AM Needham & Company Reiterates Buy Rating, $36 Price Target on Collegium Pharmaceutical (COLL), Believes "COLL's Current Valuations Fails to Capture Growth Prospects"

Apr 7, 2022 04:47PM Collegium to Participate in Upcoming Needham Healthcare Conference

Apr 7, 2022 04:47PM Collegium to Participate in Upcoming Needham Healthcare Conference

Apr 5, 2022 01:54PM Collegium Pharmaceutical (COLL) PT Raised to $36 at Needham & Company on Updated Guidance, Immediate Synergies with BDSI

Feb 15, 2022 06:21AM Collegium Pharmaceutical (COLL) PT Hiked to $34 at Needham & Company on Anticipated BioDelivery (BDSI) Synergies

Nov 12, 2021 03:29PM Collegium Pharmaceutical (COLL) PT Raised to $28 at Needham & Company

Nov 5, 2021 07:43AM Collegium Pharmaceutical (COLL) PT Lowered to $26 at Needham & Company

Dec 29, 2020 08:26AM Collegium Pharmaceutical (COLL) Added to Conviction List at Needham on Diversifying Revenue Base

Apr 7, 2020 04:01PM Collegium to Participate in Upcoming Investor Conference

Apr 7, 2020 04:01PM Collegium to Participate in Upcoming Investor Conference

Jan 8, 2020 07:21AM Collegium Pharmaceutical (COLL) PT Raised to $36 at Needham & Company

Oct 30, 2019 07:16AM Collegium Pharmaceutical (COLL) PT Lowered to $25 at Needham & Company

Apr 1, 2019 08:00AM Collegium to Present at Upcoming Investor Conferences

Apr 1, 2019 08:00AM Collegium to Present at Upcoming Investor Conferences

Mar 16, 2018 08:06AM Collegium to Present at Upcoming Investor Conferences

Mar 16, 2018 08:06AM Collegium to Present at Upcoming Investor Conferences

Feb 7, 2018 06:12AM Collegium Pharmaceutical (COLL) PT Raised to $35 at Needham & Company

Dec 5, 2017 06:53AM Collegium Pharmaceutical (COLL) PT Raised to $28 at Needham & Company; Depomed Deal to Add $3-$5 to Valuation

Oct 5, 2017 07:30AM Collegium Pharma (COLL): OxyContin Out, Xtampza In At Cigna - Needham

Jun 9, 2017 06:15AM Collegium Pharma (COLL): Removal of Opana ER A Positive - Needham

May 31, 2017 07:10AM Collegium Pharma (COLL): Management Changes A Positive - Needham

Apr 18, 2017 09:22AM Collegium Pharmaceutical (COLL) PT Lowered to $28 at Needham & Company; 'Expect Re-Acceleration of Rx Growth in 2Q17'

Mar 28, 2017 04:01PM Collegium to Present at the 16th Annual Needham Healthcare Conference

Nov 29, 2016 07:30AM Collegium Announces Underwriters’ Exercise of Option to Purchase Additional Shares

Oct 26, 2016 09:02AM Collegium Pharma (COLL) Prices 5M Share Stock Offering for Proceeds of $80M

Oct 26, 2016 09:00AM Collegium Prices Public Offering of $80 million of Common Stock

Sep 14, 2016 08:26AM Needham & Company Reiterates Buy on Collegium Pharma (COLL) Following Investor Meetings

May 26, 2016 07:23AM Collegium Pharmaceutical (COLL): Xtampza's Differentiated ADF Label Bodes Well for Competitive Opioid Market - Needham

Apr 8, 2016 08:00AM Collegium to Present at the 15th Annual Needham Healthcare Conference

Jan 8, 2016 06:02AM Collegium Pharma (COLL) Prices 2.75M Common Stock Offering at $20/Share

Jan 8, 2016 06:00AM Collegium Pharmaceutical, Inc. Prices Public Offering of $55.0 Million of Common Stock

Sep 14, 2015 07:23AM Collegium Pharmaceutical (COLL) 'Wows' FDA AdCom, Needham & Company Notes

Jun 1, 2015 07:05AM Needham & Company Starts Collegium Pharmaceutical (COLL) at Buy

May 12, 2015 04:05PM Collegium Pharmaceutical Announces Closing of Its Initial Public Offering and Exercise in Full of Option to Purchase Additional Shares

May 7, 2015 10:33AM Collegium Pharmaceutical (COLL) IPO Opens Flat

May 7, 2015 07:46AM Collegium Pharma (COLL) Prices 5.8M Common IPO at $12/Share

May 7, 2015 07:45AM Collegium Pharmaceutical Announces Pricing of Its Initial Public Offering

Apr 2, 2015 05:14PM Collegium Pharmaceutical (COLL) Files $86.25M Common IPO

View Older Stories